Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study

BACKGROUND: Patterns of healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder (GAD) have not been well characterized. METHODS: Using a large US health insurance database, we identified all patients with evidence of GAD (ICD-9-CM diagnosis code 300.02...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Ariel, Edelsberg, John, Bollu, Vamsi, Alvir, Jose Ma J, Dugar, Ashish, Joshi, Ashish V, Oster, Gerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266199/
https://www.ncbi.nlm.nih.gov/pubmed/22151689
http://dx.doi.org/10.1186/1471-244X-11-193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266199/
https://www.ncbi.nlm.nih.gov/pubmed/22151689
http://dx.doi.org/10.1186/1471-244X-11-193

Ejemplares similares